Predict your next investment

Private Equity

See what CB Insights has to offer

Investments

162

Portfolio Exits

52

About Nite Capital Management

Nite Capital Management is a private equity and venture capital firm specializing in private financing for small-cap and micro-cap public companies. The firm seeks to invest in technology (software, Internet, telecommunications, etc.), biotechnology, health care, nanotechnology, energy, real estate, and others sectors.

Nite Capital Management Headquarter Location

100 East Cook Avenue Suite 201

Libertyville, Illinois, 60048,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Nite Capital Management Investments

162 Investments

Nite Capital Management has made 162 investments. Their latest investment was in OncoVista Innovative Therapies as part of their Unattributed VC on August 8, 2007.

CBI Logo

Nite Capital Management Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/17/2007

Unattributed VC

OncoVista Innovative Therapies

$6.79M

Yes

1

7/23/2007

Private Equity - IV

Satcon Technology Corporation

$4.76M

No

7/11/2007

PIPE - III

EpiCept

$10M

No

6/21/2007

Unattributed VC - III

Subscribe to see more

$99M

Subscribe to see more

0

6/11/2007

Unattributed VC

Subscribe to see more

$99M

Subscribe to see more

0

Date

8/17/2007

7/23/2007

7/11/2007

6/21/2007

6/11/2007

Round

Unattributed VC

Private Equity - IV

PIPE - III

Unattributed VC - III

Unattributed VC

Company

OncoVista Innovative Therapies

Satcon Technology Corporation

EpiCept

Subscribe to see more

Subscribe to see more

Amount

$6.79M

$4.76M

$10M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

0

0

Nite Capital Management Portfolio Exits

52 Portfolio Exits

Nite Capital Management has 52 portfolio exits. Their latest portfolio exit was Antares Pharma on May 24, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/24/2022

Acq - P2P

$99M

5

8/28/2020

Take Private

$99M

3

6/8/2020

Take Private

$99M

Undisclosed Investors

1

9/12/2018

Reverse Merger

Subscribe to see more

$99M

Subscribe to see more

10

6/28/2018

Asset Sale

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/24/2022

8/28/2020

6/8/2020

9/12/2018

6/28/2018

Exit

Acq - P2P

Take Private

Take Private

Reverse Merger

Asset Sale

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Undisclosed Investors

Subscribe to see more

Subscribe to see more

Sources

5

3

1

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.